Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 1, 2013, Pages 6-16

  Strong, Randy ^a,b,c   Miller, Richard A ^d   Astle, Clinton M ^e   Baur, Joseph A ^f,g   De Cabo, Rafael ^h   Fernandez, Elizabeth ^a,b,c   Guo, Wen ⁱ   Javors, Martin ^b   Kirkland, James L ^j   Nelson, James F ^c   Sinclair, David A ^k   Teter, Bruce ^l   Williams, David ^m   Zaveri, Nurulain ⁿ   Nadon, Nancy L ^h   Harrison, David E ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e JACKSON LABORATORY   (United States)

^f Department of Physiology ^*  (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h NATIONAL INSTITUTE ON AGING   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j MAYO CLINIC   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ Astraea Therapeutics Inc   (Spain)

more..

Author keywords

aging; diet; Interventions; Longevity; mice

Indexed keywords

MUS;

CURCUMIN; OXALOACETIC ACID; RESVERATROL; STILBENE DERIVATIVE; TRIACYLGLYCEROL;

AGE; AGING; ANIMAL; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; C3H MOUSE; C57BL MOUSE; CHEMISTRY; DBA MOUSE; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETICS; LONGEVITY; MALE; MOTOR ACTIVITY; MOUSE; PATHOLOGY; PHYSIOLOGY; PREGNANCY; SEXUAL DEVELOPMENT; TEA;

AGE FACTORS; AGING; ANIMALS; BODY WEIGHT; CURCUMIN; DRUG EVALUATION, PRECLINICAL; FEMALE; LONGEVITY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MODELS, ANIMAL; MOTOR ACTIVITY; OXALOACETIC ACID; PREGNANCY; SEX CHARACTERISTICS; STILBENES; TEA; TRIGLYCERIDES;

EID: 84871876229     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls070     Document Type: Article

References (44)

1. Miller RA. Extending life: scientific prospects and political obstacles. Milbank Q. 2002;80(1):155-174.
2. Olshansky SJ, Carnes BA, Cassel C. In search of Methuselah: estimating the upper limits to human longevity. Science. 1990;250(4981):634-640.
3. Olshansky SJ. Commentary: prescient visions of public health from Cornaro to Breslow. Int J Epidemiol. 2006;35(1):22-23.
4. Archer JR, Harrison DE. L-Deprenyl treatment in aged mice slightly increases life spans, and greatly reduces fecundity by aged males. J Gerontol A Biol Sci Med Sci. 1996;51(6):B448-B453.
5. Schneider EL, Reed JD Jr. Life extension. N Engl J Med. 1985; 312(18):1159-1168.
6. Cotzias GC, Miller ST, Tang LC, Papavasiliou PS. Levodopa, fertility, and longevity. Science. 1977;196(4289):549-551.
7. Miller RA, Harrison DE, Astle CM, et al. An Aging Interventions Testing Program: study design and interim report. Aging Cell. 2007; 6(4):565-575.
8. Strong R, Miller RA, Astle CM, et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 2008;7(5):641-650.
9. Nadon NL, Strong R, Miller RA, et al. Design of aging intervention studies: the NIA Interventions Testing Program. Age (Dordr). 2008; 30(4):187-199.
10. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253):392-395.
11. Miller RA, Harrison DE, Astle CM, et al. Rapamycin, but not resvera-trol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66(2):191-201.
12. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol. 2006; 16(3):296-300.
13. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117): 337-342.
14. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8(2):157-168.
15. Kitani K, Yokozawa T, Osawa T. Interventions in aging and age-associated pathologies by means of nutritional approaches. Ann N Y Acad Sci. 2004;1019:424-426.
16. Kitani K, Osawa T, Yokozawa T. The effects of tetrahydrocurcumin and green tea polyphenol on the survival of male C57BL/6 mice. Biogerontology. 2007;8(5):567-573.
17. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys. 1995; 322(2):339-346.
18. Pietta PG. Flavonoids as antioxidants. J Nat Prod. 2000;63(7): 1035-1042.
19. Han J, Hamilton JA, Kirkland JL, Corkey BE, Guo W. Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. Obes Res. 2003;11(6):734-744.
20. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science. 2003;299(5606): 572-574.
21. Williams DS, Cash A, Hamadani L, Diemer T. Oxaloacetate supplementation increases lifespan in Caenorhabditis elegans through an AMPK/FOXO-dependent pathway. Aging Cell. 2009;8(6): 765-768.
22. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506.
23. Wood JG, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430(7000): 686-689.
24. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L. Effects of resveratrol on lifespan in Drosophila melanogaster and Cae-norhabditis elegans. Mech Ageing Dev. 2007;128(10):546-552.
25. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18): 2081-2087.
26. Frank N, Knauft J, Amelung F, Nair J, Wesch H, Bartsch H. No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat Res. 2003;523-524:127-135.
27. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847-6854.
28. Frautschy SA, Hu W, Kim P, et al. Phenolic anti-inflammatory antiox-idant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging. 2001;22(6):993-1005.
29. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21(21): 8370-8377.
30. Kumar PA, Suryanarayana P, Reddy PY, Reddy GB. Modulation of alpha-crystallin chaperone activity in diabetic rat lens by curcumin. Mol Vis. 2005;11:561-568.
31. Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci. 2005;46(6): 2092-2099.
32. Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 1992;36(4):273-275.
33. Soudamini KK, Unnikrishnan MC, Soni KB, Kuttan R. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol. 1992;36(4):239-243.
34. Alden CJ. Toxicology and Carcinogenesis Studies of Turmeric Oleo-resin (Major Component 79%-85% Curcumin) in F344/N Rats and B6C3F1 Mice. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health; 1993. National Toxicology Program Technical Report Series No. 427.
35. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci. 2006;78(18): 2073-2080.
36. Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-part 1. Curr Oncol. 2006;13(1):14-26.
37. Yang JA, Choi JH, Rhee SJ. Effects of green tea catechin on phospho-lipase A2 activity and antithrombus in streptozotocin diabetic rats. J Nutr Sci Vitaminol (Tokyo). 1999;45(3):337-346.
38. Khan SG, Katiyar SK, Agarwal R, Mukhtar H. Enhancement of anti-oxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res. 1992;52(14):4050-4052.
39. Kimura M, Umegaki K, KasuyaY, Sugisawa A, Higuchi M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr. 2002;56(12): 1186-1193.
40. Luczaj W, Waszkiewicz E, Skrzydlewska E, Roszkowska-Jakimiec W. Green tea protection against age-dependent ethanol-induced oxidative stress. J Toxicol Environ Health A. 2004;67(7):595-606.
41. Crozier G, Bois-Joyeux B, Chanez M, Girard J, Peret J. Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. Metabolism. 1987;36(8):807-814.
42. St Onge MP, Ross R, Parsons WD, Jones PJ. Medium-chain triglycer-ides increase energy expenditure and decrease adiposity in overweight men. Obes Res. 2003;11(3):395-402.
43. Kono H, Fujii H, Asakawa M, et al. Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann Surg. 2003;237(2):246-255.
44. Reger MA, Henderson ST, Hale C, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004;25(3): 311-314.